myNEO - Personalised platform for cancer

myneo.me

Ghent, Flanders, Belgium

11-50 employees

LinkedIn Profile

About myNEO - Personalised platform for cancer

immunotherapy, big data, cancer vaccine, dark genome, ai, biotechnology research, oncology, mhc presentation, whole-genome sequencing, neoms presentation predictor, camyotopes, smorfs in tumor cells, organoid validation, mrna vaccine platform, neoim immunogenicity predictor, cancer treatment, tumor-specific targets, immune response amplification, molecular diagnostics, cancer vaccine development

myNEO - Personalised platform for cancer's Tech Stack

AI/ML

Decision Makers at myNEO - Personalised platform for cancer

3 contacts

Bruno Fant

Chief Technology Officer

b***@myneo.me Sign up to view

Lore Van Oudenhove

Chief Technology Officer

l***@myneotx.com Sign up to view

Cedric Bogaert

Co-Founder, CEO

c***@myneo.me Sign up to view

Unlock full contact details including verified emails and LinkedIn profiles

Upgrade to Pro

9 technologies detected · 3 decision makers · Emails available

Sales Outreach Angle

WordPress as a CMS signals a content-driven or SMB digital presence. SEO tools, hosting solutions, and page-builder plugins are natural fits for outreach.

myNEO - Personalised platform for cancer's Position in the StackWho Database

• myNEO - Personalised platform for cancer is 1 of 7,925 research companies tracked in StackWho.
• 7,883 research companies in our database have verified decision-maker emails (99% of the cohort).
• 2,547 companies in Flanders are in the StackWho database.
• 2,948 research companies are in the 11-50 employee range (same size as myNEO - Personalised platform for cancer).

Technology detection from public web signals. Decision-maker contacts compiled from LinkedIn public profiles, company filings, and verified outbound testing. Methodology & sources · Updated July 2026.

Frequently Asked Questions

What technology does myNEO - Personalised platform for cancer use?

myNEO - Personalised platform for cancer uses Outlook, Microsoft Office 365, Google Font API, Google Tag Manager, Nginx, WordPress.org, and 3 more technologies. This data is sourced from StackWho's technology detection engine.

How do I contact the decision makers at myNEO - Personalised platform for cancer?

StackWho has verified email addresses for 3 decision makers at myNEO - Personalised platform for cancer. Pro members can access direct emails for the CEO, CTO, VP of Engineering, and other key contacts. Use StackWho to reach myNEO - Personalised platform for cancer directly for sales, recruiting, or partnerships.

What industry is myNEO - Personalised platform for cancer in?

myNEO - Personalised platform for cancer operates in the research industry, headquartered in Ghent, Flanders, Belgium. StackWho tracks technology stacks and decision maker contacts for companies across all industries.

Can I export myNEO - Personalised platform for cancer's contact data?

Yes. StackWho Pro members can export decision maker contact data for myNEO - Personalised platform for cancer and similar companies to CSV. Use the export feature to build targeted prospect lists segmented by technology stack, industry, or location.